No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX241220P85000
- 0.05
- -0.10-66.67%
15min DelayClose Dec 17 16:00 ET
0.05High0.05Low
0.05Open0.15Pre Close1 Volume775 Open Interest85.00Strike Price5.00Turnover44.67%IV6.06%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0383Delta0.0259Gamma1808.60Leverage Ratio-0.0420Theta-0.0002Rho-69.34Eff Leverage0.0060Vega
Intraday
- 5D
- Daily
News
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $110
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know
Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Optimistic Outlook for Boston Scientific's Urology Segment Drives Buy Recommendation
FDA Roundup: December 17, 2024